Article

A healthy lifestyle lowers lifetime risk of heart failure in men

Adherence to healthy lifestyle factors is associated with a lower lifetime risk of heart failure in apparently healthy men compared with the general population. The lifetime risk is higher in men who have hypertension than in those who do not.

Adherence to healthy lifestyle factors is associated with a lower lifetime risk of heart failure in apparently healthy men compared with the general population. The lifetime risk is higher in men who have hypertension than in those who do not.

Djouss and colleagues prospectively evaluated data obtained from 20,900 men enrolled in the Physicians’ Health Study. They specifically examined how modifiable cardiac risk factors-body weight, smoking status, alcohol intake, exercise participation, and diet-affect the lifetime risk of heart failure.

Overall, the lifetime risk of heart failure was 13.8% at age 40 years and remained constant through age 70 years. The remaining lifetime risk of heart failure was about 2% to 4% higher in men with hypertension than in those without. The more healthy behaviors a man had, the lower his risk; among men with no healthy behaviors, the lifetime risk was about 1 in 5-the highest observed in the study-compared with a 1 in 10 risk among men embracing 4 or more healthy habits (eg, healthy diet, regular exercise).

The authors suggested that confirmation of the influence of modifiable lifestyle factors on the life-time risk of heart failure is warranted in other patient populations.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.